Does NIROGACESTAT Cause Product dose omission issue? 60 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 60 reports of Product dose omission issue have been filed in association with NIROGACESTAT (OGSIVEO). This represents 12.1% of all adverse event reports for NIROGACESTAT.
60
Reports of Product dose omission issue with NIROGACESTAT
12.1%
of all NIROGACESTAT reports
0
Deaths
4
Hospitalizations
How Dangerous Is Product dose omission issue From NIROGACESTAT?
Of the 60 reports, 4 (6.7%) required hospitalization.
Is Product dose omission issue Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for NIROGACESTAT. However, 60 reports have been filed with the FAERS database.
What Other Side Effects Does NIROGACESTAT Cause?
Diarrhoea (220)
Nausea (136)
Fatigue (110)
Headache (62)
Rash (59)
Vomiting (50)
Stomatitis (42)
Product dose omission in error (34)
Cough (33)
Pruritus (31)
What Other Drugs Cause Product dose omission issue?
DUPILUMAB (18,189)
USTEKINUMAB (9,405)
GUSELKUMAB (9,267)
LENALIDOMIDE (8,145)
MEPOLIZUMAB (5,873)
TOFACITINIB (5,646)
VOXELOTOR (5,122)
BELIMUMAB (4,671)
SECUKINUMAB (4,572)
APREMILAST (4,460)
Which NIROGACESTAT Alternatives Have Lower Product dose omission issue Risk?
NIROGACESTAT vs NIROGACESTAT HYDROBROMIDE
NIROGACESTAT vs NIRSEVIMAB
NIROGACESTAT vs NIRSEVIMAB-ALIP
NIROGACESTAT vs NITAZOXANIDE
NIROGACESTAT vs NITISINONE